ProCE Banner Activity

REACH: Adherence to Dapivirine Vaginal Ring and Oral PrEP Among Adolescent Girls and Young Women in Africa

Slideset Download
Conference Coverage
Adherence to the dapivirine vaginal ring and oral PrEP was higher than anticipated over 12 months, with rates reaching 50% to 59% depending on the modality.

Released: July 24, 2021

Expiration: July 23, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner